Delivery Order SPE2DB20D1004-SPE2DB25FNHUS
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.72 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.73 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count) with a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the federal government's...
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $27,922.67 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with a firm fixed price structure. The contract is non-competitive and represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for 180 capsules of Mesalamine 400 mg. This competitively awarded, firm fixed-price delivery order was valued at $13,074.78 and completed on May 21, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,879.92 contract is for the supply of 180 count capsules of the drug Mesalamine DR 400 mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency awarded a delivery order valued at $17,820.21 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a pharmaceutical treatment primarily used for inflammatory bowel...
- The Defense Logistics Agency awarded a $17,647.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mesalamine is a therapeutic medication used primarily to treat inflammatory bowel conditions, and this...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 400 mg capsules (180s). The contract has a ceiling value of $2,632.04 and a completion date of June 13, 2025. The award is not set aside and was made on June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00,...